|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-3-15
|
|
pubmed:abstractText |
Although emerging data suggest that zoledronic acid (Zol) may have different anti-tumour activities against a broad range of cancers, its effects on lung cancer remain largely unknown. The aim of this study was to evaluate in vitro the anti-tumoural and anti-angiogenetic effect of zoledronic acid in non-small-cell lung cancer (NSCLC) cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1365-2184
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2011 Blackwell Publishing Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
139-46
|
|
pubmed:meshHeading |
pubmed-meshheading:21401755-Angiogenesis Inhibitors,
pubmed-meshheading:21401755-Apoptosis,
pubmed-meshheading:21401755-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:21401755-Cell Line, Tumor,
pubmed-meshheading:21401755-Cyclins,
pubmed-meshheading:21401755-Diphosphonates,
pubmed-meshheading:21401755-G1 Phase,
pubmed-meshheading:21401755-Humans,
pubmed-meshheading:21401755-Imidazoles,
pubmed-meshheading:21401755-Inhibitor of Apoptosis Proteins,
pubmed-meshheading:21401755-Lung Neoplasms,
pubmed-meshheading:21401755-Vascular Endothelial Growth Factor A
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line.
|
|
pubmed:affiliation |
Division of Medical Oncology, Catholic University of Sacred Heart, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article
|
